Pharmaceutical

Phare Bio receives ARPA-H funds for AI drug discovery platform

Phare Bio has received up to $27m from the Advanced Research Projects Agency for Health (ARPA-H) to advance its drug discovery platform

Sep 28, 2024 - 04:00
Phare Bio receives ARPA-H funds for AI drug discovery platform
Phare Bio has received up to $27m from the Advanced Research Projects Agency for Health (ARPA-H) to advance its drug discovery platform
Read the original article

Tags:

Previous Article

Tempus AI expands oncology collaboration with Takeda

Next Article

Physicians highlight need for improved non-opioid treatments for opioid use diso...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

With little FDA oversight, melatonin supplements vary widely in actual dosage, study finds

With little FDA oversight, melatonin supplements vary w...

Apr 25, 2023

Carmell to merge with regenerative medicine company Axolotl

Carmell to merge with regenerative medicine company Axo...

Jul 29, 2023

STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback

STAT+: Pharmalittle: Lilly sues spas and compounders ov...

Sep 20, 2023